http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19917548-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42da3355f296fba182e3428555926600 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 1999-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83977612a160459e6cc90fe26bba9cea |
| publicationDate | 2000-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-19917548-A1 |
| titleOfInvention | Pharmaceutical composition based on erythromycin fatty acid salts with 12 to 22 carbon atoms in the fatty acid residue and use of these erythromycin fatty acid salts for the topical treatment of skin diseases |
| abstract | The invention relates to a pharmaceutical composition which contains at least one erythromycin fatty acid salt with 12 to 22 carbon atoms in the fatty acid residue and a liquid or viscous carrier. The invention further relates to the use of these erythromycin fatty acid salts for the topical treatment of skin diseases, in particular for the treatment of acne. This pharmaceutical composition is characterized by high stability even when stored over a longer period of time, good penetration into the skin and high skin tolerance. |
| priorityDate | 1999-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.